MRD Clinical Account Executive – Utah & Wyoming

Tempus AI; Utah; Sur place; USD 90 000 - 150 000; Plein temps

Résumé du poste

Tempus AI is seeking a Clinical Account Executive to promote MRD testing services to clinicians and healthcare providers in Utah/Wyoming. You will lead strategic business development, engage with senior stakeholders, and drive adoption within academic medical centers, health systems, and community practices.

You will collaborate with Tempus teams, manage accounts, and develop plans to maximize contracting opportunities while navigating payer and reimbursement landscapes in oncology diagnostics.

Qualifications

• Direct account management experience in molecular diagnostics or related field.
• Proven revenue generation in health care diagnostics or biotech.
• Experience with major cancer centers, oncology GPOs, health systems.

Responsabilités

• Promote Tempus MRD testing services to clinicians and healthcare providers within the territory.
• Engage KOLs, clinicians, and decision-makers to create and grow opportunities.
• Develop strategic plans for client acquisition and retention, including contracting opportunities.
• Collaborate with sales teams to meet company goals and objectives.
• Identify partnerships between oncology clients and Tempus to integrate MRD testing into practice.

Connaissances

Consultative selling

Executive-level engagement

Payer/reimbursement knowledge

Project management

Communications

Cross-functional collaboration

MS Office / Salesforce

Formation

B.S. in life science / biology / business / marketing

MBA preferred

Outils

Salesforce.com

Excel

PowerPoint

Description du poste

Tempus AI is seeking a Clinical Account Executive to promote MRD testing services to clinicians and healthcare providers in Utah/Wyoming. You will lead strategic business development, engage with senior stakeholders, and drive adoption within academic medical centers, health systems, and community practices.

You will collaborate with Tempus teams, manage accounts, and develop plans to maximize contracting opportunities while navigating payer and reimbursement landscapes in oncology diagnostics.